azd1656
Small moleculeexperimental
Clinical trial activity
26 trials · 16 clinical orgs · 0 marketing orgs
Phase 1
20
Phase 2
6
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2008 (NCT00726427)
Timeline
Indications
Mechanism of action
- Hexokinase type IVACTIVATOR
GCK activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- azd1656
- azd1656
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04516759 | Phase 2 | Aug 12, 2020 | Barts & The London NHS Trust, St. George Private Hospital |
| NCT05216172 | Phase 2 | Jan 21, 2020 | AstraZeneca, Barts & The London NHS Trust, University of London |
| NCT01221545 | Phase 1 | Oct 1, 2010 | AstraZeneca, Profil GmbH |
| NCT01221519 | Phase 1 | Sep 1, 2010 | AstraZeneca, Prism Research |
| NCT01103622 | Phase 1 | Jun 1, 2010 | AstraZeneca, Profil GmbH |
| NCT01152385 | Phase 2 | May 1, 2010 | AstraZeneca |
| NCT01103609 | Phase 1 | Apr 1, 2010 | AstraZeneca, IQVIA |
| NCT01095991 | Phase 1 | Mar 1, 2010 | AstraZeneca, Profil GmbH |
| NCT01083212 | Phase 1 | Mar 1, 2010 | AstraZeneca, IQVIA, J.J. Berzelius Clinical Research Center AB |
| NCT01096940 | Phase 1 | Mar 1, 2010 | AstraZeneca, PRACS |
| NCT01069926 | Phase 1 | Mar 1, 2010 | AstraZeneca, University of Tennessee |
| NCT01082120 | Phase 1 | Feb 1, 2010 | AstraZeneca, Profil GmbH |
| NCT01020123 | Phase 2 | Oct 1, 2009 | AstraZeneca, University of Liverpool |
| NCT00995787 | Phase 1 | Oct 1, 2009 | AstraZeneca, Profil GmbH |
| NCT00916604 | Phase 1 | May 1, 2009 | AstraZeneca, PS Clinic, Fukuoka, Japan, University of Tokyo |
| NCT00817271 | Phase 1 | Feb 1, 2009 | AstraZeneca, Profil GmbH |
| NCT00856908 | Phase 2 | Feb 1, 2009 | AstraZeneca, Profil GmbH |
| NCT00819884 | Phase 1 | Jan 1, 2009 | AstraZeneca, Healthcare Discoveries Inc. |
| NCT00817778 | Phase 2 | Jan 1, 2009 | AstraZeneca, Healthcare Discoveries Inc. |
| NCT00817505 | Phase 1 | Dec 1, 2008 | AstraZeneca, Healthcare Discoveries Inc. |
Showing 20 of 26 trials
Page 1 / 2
Organizations
Research & Development (16)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AstraZeneca | For profit | 25 | 24 | 2 | 2008 |
| Profil GmbH | For profit | 10 | 0 | 2 | 2008 |
| Healthcare Discoveries Inc. | For profit | 4 | 0 | 2 | 2008 |
| Barts & The London NHS Trust | Academic/Hospital | 2 | 0 | 1 | 2020 |
| IQVIA | For profit | 2 | 0 | 1 | 2010 |
| California Clinical Trials | For profit | 1 | 0 | 1 | 2008 |
| J.J. Berzelius Clinical Research Center AB | For profit | 1 | 0 | 1 | 2010 |
| PRACS | For profit | 1 | 0 | 1 | 2010 |
| Prism Research | For profit | 1 | 0 | 1 | 2010 |
| PS Clinic, Fukuoka, Japan | Academic/Hospital | 1 | 0 | 1 | 2009 |
| St. George Private Hospital | Academic/Hospital | 1 | 1 | 1 | 2020 |
| University of Liverpool | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2020 |
| University of Tennessee | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of Tokyo | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Veeda Clinical Research | For profit | 1 | 0 | 1 | 2008 |
16 organizations
Page 1 / 1